A phase I dose escalation study of the pharmacokinetics and tolerability of ZK 304709, an oral multi-targeted growth inhibitor (MTGI™), in patients with advanced solid tumours
Edwina N. Scott, Anne L. Thomas, L. Rhoda Molife, Samreen Ahmed, Sarah Blagden, Peter C. Fong, Kristin Kowal, Candice McCoy, Herbert Wiesinger, Will Steward, Johann De BonoVolume:
64
Language:
english
Pages:
5
DOI:
10.1007/s00280-009-0968-y
Date:
July, 2009
File:
PDF, 253 KB
english, 2009